PepperLime Health Acquisition Corporation Warrrant
PEPLW
PEPLW was delisted on the 21st of March, 2024.
23 hedge funds and large institutions have $1.88M invested in PepperLime Health Acquisition Corporation Warrrant in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
5% more funds holding
Funds holding: 22 → 23 (+1)
73% less capital invested
Capital invested by funds: $6.93M → $1.88M (-$5.05M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$6.16K |
| 2 |
CIM
Cowen Investment Management
New York
|
+$4.2K |
| 3 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
+$1.6K |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$948 |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$878 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$154K |
| 2 |
RA
Ramius Advisors
New York
|
-$1.43K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$1K |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
-$326 |
| 5 |
CS
Clear Street
New York
|
-$17 |
PEPLW Hedge Fund Activity: Q1 2023 in Review
23 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in PepperLime Health Acquisition Corporation Warrrant (PEPLW) for Q1 2023, worth a combined $1.88M — down 73% from $6.93M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PEPLW positions and 5 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $6.16K. The largest seller was Mangrove Partners, exiting entirely with an estimated $154K sold.
- 23 institutional investors held PepperLime Health Acquisition Corporation Warrrant (PEPLW) as of Q1 2023, up from 22 in Q4 2022.
- Funds reported $1.88M of PepperLime Health Acquisition Corporation Warrrant stock for Q1 2023, down 73% quarter-over-quarter.
- 6 funds opened new PepperLime Health Acquisition Corporation Warrrant positions in Q1 2023 and 5 closed out, a net change of +1 holder.
- The largest PepperLime Health Acquisition Corporation Warrrant buyer in Q1 2023 was UBS O'Connor, an estimated $6.16K added.
- The largest PepperLime Health Acquisition Corporation Warrrant seller in Q1 2023 was Mangrove Partners, an estimated $154K sold.
Based on aggregated 13F filings for Q1 2023.